Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Mertz

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Infection Control and Hospital Epidemiology|March 7, 2022
Antimicrobial use in Canadian acute-care hospitals: Findings from three national point-prevalence surveys between 2002 and 2017Jennifer J Liang, Wallis Rudnick, Robyn Mitchell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2023
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic ReviewCarson K L Lo, Adam S Komorowski, Clayton W Hall, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 8, 2024
Nirmatrelvir-ritonavir use among adults hospitalized with COVID-19 during the Omicron phase of the COVID-19 pandemic, Canadian Nosocomial Infection Surveillance ProgramRobyn Mitchell, Diane Lee, Linda Pelude, et al.
Journal of Clinical Epidemiology|January 26, 2013
Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysisMalgorzata M Bala, Elie A Akl, Xin Sun, et al.
The Journal of Rheumatology|May 16, 2021
Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic DiseasesGlen S Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, et al.
The Journal of Infection|January 30, 2018
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS studyChristina Orasch, Dominik Mertz, Jorge Garbino, et al.
BMJ (Clinical Research Ed.)|March 17, 2012
Credibility of claims of subgroup effects in randomised controlled trials: systematic reviewXin Sun, Matthias Briel, Jason W Busse, et al.
Trials|November 11, 2009
Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trialsXin Sun, Matthias Briel, Jason W Busse, et al.
BMJ (Clinical Research Ed.)|March 30, 2011
The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic reviewXin Sun, Matthias Briel, Jason W Busse, et al.
JAMA Network Open|September 3, 2025
Nonregistration, Discontinuation, and Nonpublication of Randomized Trials: A Systematic ReviewBenjamin Speich, Ala Taji Heravi, Christof M Schönenberger, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Infection Control and Hospital Epidemiology|March 7, 2022
Antimicrobial use in Canadian acute-care hospitals: Findings from three national point-prevalence surveys between 2002 and 2017Jennifer J Liang, Wallis Rudnick, Robyn Mitchell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2023
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic ReviewCarson K L Lo, Adam S Komorowski, Clayton W Hall, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 8, 2024
Nirmatrelvir-ritonavir use among adults hospitalized with COVID-19 during the Omicron phase of the COVID-19 pandemic, Canadian Nosocomial Infection Surveillance ProgramRobyn Mitchell, Diane Lee, Linda Pelude, et al.
Journal of Clinical Epidemiology|January 26, 2013
Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysisMalgorzata M Bala, Elie A Akl, Xin Sun, et al.
The Journal of Rheumatology|May 16, 2021
Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic DiseasesGlen S Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, et al.
The Journal of Infection|January 30, 2018
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS studyChristina Orasch, Dominik Mertz, Jorge Garbino, et al.
BMJ (Clinical Research Ed.)|March 17, 2012
Credibility of claims of subgroup effects in randomised controlled trials: systematic reviewXin Sun, Matthias Briel, Jason W Busse, et al.
Trials|November 11, 2009
Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trialsXin Sun, Matthias Briel, Jason W Busse, et al.
BMJ (Clinical Research Ed.)|March 30, 2011
The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic reviewXin Sun, Matthias Briel, Jason W Busse, et al.
JAMA Network Open|September 3, 2025
Nonregistration, Discontinuation, and Nonpublication of Randomized Trials: A Systematic ReviewBenjamin Speich, Ala Taji Heravi, Christof M Schönenberger, et al.
Pageof 15